فبوکسوستات (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "فبوکسوستات" in Persian language version.

refsWebsite

Global rank Persian rank

399^th place

104^th place

447^th place

382^nd place

3,984^th place

1,143^rd place

3,258^th place

1,207^th place

1web.archive.org

1^st place

1^st place

6^th place

9^th place

2^nd place

2^nd place

4^th place

5^th place

1semanticscholar.org

11^th place

52^nd place

archive.org

Love BL, Barrons R, Veverka A, Snider KM (June 2010). "Urate-lowering therapy for gout: focus on febuxostat". Pharmacotherapy. 30 (6): 594–608. doi:10.1592/phco.30.6.594. PMID 20500048. S2CID 6617778.

doi.org

Love BL, Barrons R, Veverka A, Snider KM (June 2010). "Urate-lowering therapy for gout: focus on febuxostat". Pharmacotherapy. 30 (6): 594–608. doi:10.1592/phco.30.6.594. PMID 20500048. S2CID 6617778.

drugs.com

"Febuxostat (Uloric) Use During Pregnancy". Drugs.com. 22 February 2019. Retrieved 17 May 2020.
"Febuxostat Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 26 February 2019.

fda.gov

fda.gov

"Drug Safety and Availability - FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)". FDA. 21 February 2019. Retrieved 26 February 2019.

accessdata.fda.gov

"Uloric label" (PDF). U.S. Food and Drug Administration. February 2009.

nice.org.uk

"Febuxostat for the management of hyperuricaemia in people with gout Guidance and guidelines". www.nice.org.uk. 17 December 2008. Archived from the original on 28 March 2017. Retrieved 28 March 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Love BL, Barrons R, Veverka A, Snider KM (June 2010). "Urate-lowering therapy for gout: focus on febuxostat". Pharmacotherapy. 30 (6): 594–608. doi:10.1592/phco.30.6.594. PMID 20500048. S2CID 6617778.

semanticscholar.org

api.semanticscholar.org

Love BL, Barrons R, Veverka A, Snider KM (June 2010). "Urate-lowering therapy for gout: focus on febuxostat". Pharmacotherapy. 30 (6): 594–608. doi:10.1592/phco.30.6.594. PMID 20500048. S2CID 6617778.

tga.gov.au

"Prescription medicines: registration of new chemical entities in Australia, 2014". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 10 April 2023.

web.archive.org

"Febuxostat for the management of hyperuricaemia in people with gout Guidance and guidelines". www.nice.org.uk. 17 December 2008. Archived from the original on 28 March 2017. Retrieved 28 March 2017.